Jim Cramer says these 5 Nasdaq losers could rebound in 2023

Jim Cramer says these 5 Nasdaq losers could rebound in 2023


Cramer explains why Airbnb stock got crushed last year

CNBC’s Jim Cramer on Friday named four stocks that he believes could mount a comeback this year.

To come up with his picks, he parsed through last year’s worst-performing stocks listed in the Nasdaq 100. 

“Out of the Nasdaq’s biggest losers, I think Qualcomm, Lam Research, Micron, and Airbnb will work this year, although not necessarily the first half,” he said, adding, “and don’t forget Illumina.”

Here are his thoughts on each stock:

Qualcomm

  • Cramer said that while Wall Street expects the semiconductor company to start losing iPhone orders in 2024, it’s possible the company could hold to at least some of those orders due. The company’s push into the auto market should also help the stock, he added.

Lam Research

  • He acknowledged that the near future could be ugly for chipmakers. However, “you can’t afford to wait around too long after this next bad quarter, because Lam’s stock will bottom months before the business does,” he said.

Micron

  • He advised investors to wait several months to buy shares of Micron, but make sure to do so before the chip glut is over. “Once there’s any sign of a bottom, this thing will bounce back like crazy — always has,” he said.

Airbnb

  • Cramer said that the company should continue to make money this year thanks to the current travel boom. Investors interested in the stock should buy it gradually on the way down, he added.

Illumina

  • He said that while the company is “superb,” he’d rather own shares of Danaher than Illumina.

Disclaimer: Cramer’s Charitable Trust owns shares of Qualcomm and Danaher.

Jim Cramer says these 5 Nasdaq losers could rebound in 2023

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Kimberly-Clark agrees to buy Tylenol owner Kenvue in .7 billion deal, creating consumer staples giant
Business

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue. Getty Images Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant. The deal is a combination of cash and stock. Shares of Kenvue surged 20% in premarket trading Monday, while shares […]

Read More
Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More